The effects of cardioactive drugs on cardiomyocytes derived from human induced pluripotent stem cells
スポンサーリンク
概要
- 論文の詳細を見る
Developing effective drug therapies for arrhythmic diseases is hampered by the fact that the same drug can work well in some individuals but not in others. Human induced pluripotent stem (iPS) cells have been vetted as useful tools for drug screening. However, cardioactive drugs have not been shown to have the same effects on iPS cell-derived human cardiomyocytes as on embryonic stem (ES) cell-derived cardiomyocytes or human cardiomyocytes in a clinical setting. Here we show that current cardioactive drugs affect the beating frequency and contractility of iPS cell-derived cardiomyocytes in much the same way as they do ES cell-derived cardiomyocytes, and the results were compatible with empirical results in the clinic. Thus, human iPS cells could become an attractive tool to investigate the effects of cardioactive drugs at the individual level and to screen for individually tailored drugs against cardiac arrhythmic diseases.
論文 | ランダム
- 新鎮痛剤(-)-1,4-Dimethyl-10-hydroxy-2,3,4,5,6,7-hexahydro-1,6-methano-1H-4-benzazonine Hydrobromide(l-ST-2121)のラット尿中代謝産物の合成とその鎮痛作用
- A New Synthesis of 6,7-Benzomorphan
- 0933 アデノシン及びコリン受容体に対する刺激効果の部位による相違 : 刺激伝導系と一般心筋における検討
- 248. 最近の CT 装置の動向 (1) : 第 2 次勧告ファントムによる性能評価(CT-4 性能評価)
- 248. 最近の CT 装置の動向 (1) : 第 2 次勧告ファントムによる性能評価(第 46 回総会学術大会会員研究発表予稿)